BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 19486401)

  • 21. In vitro inhibitory effect of Streblus asper leaf-extract on adhesion of Candida albicans to human buccal epithelial cells.
    Taweechaisupapong S; Choopan T; Singhara S; Chatrchaiwiwatana S; Wongkham S
    J Ethnopharmacol; 2005 Jan; 96(1-2):221-6. PubMed ID: 15588674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Candida albicans enhances invasion of human gingival epithelial cells and gingival fibroblasts by Porphyromonas gingivalis.
    Tamai R; Sugamata M; Kiyoura Y
    Microb Pathog; 2011 Oct; 51(4):250-4. PubMed ID: 21742026
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antifungal activity of Morinda citrifolia fruit extract against Candida albicans.
    Jainkittivong A; Butsarakamruha T; Langlais RP
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Sep; 108(3):394-8. PubMed ID: 19716507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antifungal activity of alpha-mangostin against Candida albicans.
    Kaomongkolgit R; Jamdee K; Chaisomboon N
    J Oral Sci; 2009 Sep; 51(3):401-6. PubMed ID: 19776506
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of Candida albicans morphogenesis by tumor necrosis factor-alpha and potential for treatment of oral candidiasis.
    Ohta H; Tanimoto T; Taniai M; Taniguchi M; Ariyasu T; Arai S; Ohta T; Fukuda S
    In Vivo; 2007; 21(1):25-32. PubMed ID: 17354610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oral epithelium-Candida glabrata interactions in vitro.
    Li L; Dongari-Bagtzoglou A
    Oral Microbiol Immunol; 2007 Jun; 22(3):182-7. PubMed ID: 17488444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histone deacetylase inhibitors may reduce pathogenicity and virulence in Candida albicans.
    Simonetti G; Passariello C; Rotili D; Mai A; Garaci E; Palamara AT
    FEMS Yeast Res; 2007 Dec; 7(8):1371-80. PubMed ID: 17627775
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antagonistic effect of Candida albicans and IFNγ on E-cadherin expression and production by human primary gingival epithelial cells.
    Rouabhia M; Semlali A; Audoy J; Chmielewski W
    Cell Immunol; 2012 Nov; 280(1):61-7. PubMed ID: 23261830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparisons of the susceptibilities of planktonic and adherent Candida albicans to antifungal agents: a modified XTT tetrazolium assay using synchronised C. albicans cells.
    Hawser S
    J Med Vet Mycol; 1996; 34(2):149-52. PubMed ID: 8732362
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intercellular adhesion molecule 1-dependent activation of interleukin 8 expression in Candida albicans-infected human gingival epithelial cells.
    Egusa H; Nikawa H; Makihira S; Jewett A; Yatani H; Hamada T
    Infect Immun; 2005 Jan; 73(1):622-6. PubMed ID: 15618204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of interleukin-18 in the inflammatory response against oropharyngeal candidiasis.
    Tardif F; Goulet JP; Zakrazewski A; Chauvin P; Rouabhia M
    Med Sci Monit; 2004 Aug; 10(8):BR239-49. PubMed ID: 15277983
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro candidacidal activity of a synthetic killer decapeptide (KP) against Candida albicans cells adhered to resin acrylic discs.
    Manfredi M; Merigo E; Salati A; Conti S; Savi A; Polonelli L; Bonanini M; Vescovi P
    J Oral Pathol Med; 2007 Sep; 36(8):468-71. PubMed ID: 17686004
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of voriconazole and fluconazole on reconstituted multilayered oesophageal epithelium infected by Candida albicans.
    Bernhardt J; Bernhardt H; Knoke M; Ludwig K
    Mycoses; 2004 Aug; 47(7):330-7. PubMed ID: 15310340
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of subinhibitory concentrations of ciclopirox on the adherence of Candida albicans to human buccal and vaginal epithelial cells.
    Braga PC; Piatti G; Conti E; Vignali F
    Arzneimittelforschung; 1992 Nov; 42(11):1368-71. PubMed ID: 1492854
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of bee propolis on oral pathogens and human gingival fibroblasts.
    Sonmez S; Kirilmaz L; Yucesoy M; Yücel B; Yilmaz B
    J Ethnopharmacol; 2005 Dec; 102(3):371-6. PubMed ID: 16084044
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of antifungal drugs on virulence properties of Candida albicans in patients with diabetes mellitus.
    Willis AM; Coulter WA; Fulton CR; Hayes JR; Bell PM; Lamey PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2001 Mar; 91(3):317-21. PubMed ID: 11250629
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of fluorides on Candida albicans.
    Flisfisch S; Meyer J; Meurman JH; Waltimo T
    Oral Dis; 2008 May; 14(4):296-301. PubMed ID: 18410574
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of verapamil on Candida albicans hyphal development, adhesion and gastrointestinal colonization.
    Yu Q; Ding X; Zhang B; Xu N; Jia C; Mao J; Zhang B; Xing L; Li M
    FEMS Yeast Res; 2014 Jun; 14(4):633-41. PubMed ID: 24650198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.